Conference Coverage (Lancet Conference)

Would Low Dose BCG Vaccine Offer Universal TB Protection?

Published in TB and Outbreaks Week, October 9th, 1995

Vaccination with much lower than standard doses of bacillus Calmette-Guerin (BCG) may provide universal protection against tuberculosis, according to noted TB researcher.

Peter Bretscher of Canada's University of Saskatchewan presented this theory at The Lancet Conference 1995, "The Challenge of Tuberculosis," held September 14 and 15 in Washington D.C.

"A standard vaccine against tuberculosis that is universally effective despite the genetic diversity of humans, would be the ideal means of preventing this disease," Bretscher wrote in an abstract presented at the conference.

"Past experience appears to hold little promise for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1995-10-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry